Earlier last month, a jury awarded the family of a woman who died from ovarian cancer roughly $72 million against the defendant, health-care manufacturing giant, Johnson & Johnson. According to one article following the case, $10 million of the verdict was for compensatory damages and $62 million were for punitive damages.
The Allegations
The plaintiffs in the case alleged that Johnson & Johnson not only sold a dangerous product, but also that the company continued to do so even after it learned the of dangers associated with the product. The lawsuit focused on the deceased’s use of Johnson & Johnson’s “Shower to Shower” powder, which contained talcum powder. The product was marketed for decades as a feminine hygiene product, until the Food and Drug Administration advised against the use of talc-based products around the genitals.
Evidence at trial suggested that the woman had used the product for decades, and was never warned of the possibility that continued use of the product increased the likelihood she would develop cancer. There was also evidence presented suggesting that Johnson & Johnson officials knew that there were dangers associated with the use of their product, but ignored them and continued to market the product as a safe feminine-hygiene product.